Pharming (PHAR) Other Non Operating Income (2019 - 2026)

Pharming (PHAR) has 8 years of Other Non Operating Income data on file, last reported at $7.1 million in Q2 2026.

• Quarterly Other Non Operating Income rose 463.66% year-over-year to $7.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $8.1 million (up 294.19% YoY) and the FY2025 annual result came in at $2.2 million, changed N/A from the prior year.
• Other Non Operating Income grew to $7.1 million in Q2 2026, from $3.2 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $9.3 million in Q4 2022 to a low of -$6.8 million in Q4 2024.
• A 5-year average of $945875.0 and a median of $714500.0 in 2024 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2023 — Other Non Operating Income tumbled 144.68% — and 2024, when it jumped 1346.34%.
• Tracing PHAR's Other Non Operating Income over 5 years: stood at $9.3 million in 2022, then slumped by 139.39% to -$3.7 million in 2023, then tumbled by 86.81% to -$6.8 million in 2024, then surged by 68.2% to -$2.2 million in 2025, then surged by 427.16% to $7.1 million in 2026.
• The last three Other Non Operating Income figures came in at $7.1 million (Q2 2026), $3.2 million (Q1 2026), and -$2.2 million (Q4 2025), per Business Quant data.